TOP2A and neoplasm: DNA Topoisomerase II Alpha (TOP2A) labelling is associated with a shorter overall and progression free survival, whilst N-MYC downstream- regulated gene 2 (NDRG2) is established as a marker of tumour aggression [24,25].